Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jose Romero

TitleContingent Worker
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPeds Pediatrics, College of Medicine
DivisionPeds Infectious Diseases
Address ACH Sturgis Building
800 Marshall Street
Mail Slot # 512-11
Little Rock AR 72202
Phone501-364-1416
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R01AG059725     (ROMERO, JOSE RAFAEL)Aug 1, 2019 - Apr 30, 2024
    NIH
    Enlarged Perivascular Spaces as Markers of Vascular and Alzheimer pathology: predictors, pathophysiology and clinical consequences
    Role: Principal Investigator
    UL1TR003107     (JAMES, LAURA P)Jul 1, 2019 - Jun 30, 2024
    NIH
    Expanding Translational Research in Arkansas
    Role: Co-Investigator
    R21CA231180     (TEETER, BENJAMIN SAMUEL)Apr 1, 2019 - Mar 31, 2021
    NIH
    Improving HPV Vaccination using Implementation Strategies in Community Pharmacies
    Role: Co-Investigator
    U54TR001629     (JAMES, LAURA P)Sep 26, 2017 - Aug 31, 2019
    NIH
    Expanding Translational Research in Arkansas
    Role: Co-Investigator
    R03AG048180     (ROMERO, JOSE RAFAEL)Jun 1, 2015 - May 31, 2018
    NIH
    Cerebral Microbleeds in Young Adults: risk factors, biomarkers and genetics
    Role: Principal Investigator
    ACRI # 034419     (ROMERO, JOSE R)Sep 28, 2014 - Sep 27, 2017
    UAMS ACHRI Flow Through
    CASG404
    Role: Principal Investigator
    ACRI#034419     (ROMERO, JOSE R)Sep 28, 2014 - Sep 27, 2017
    UAMS ACHRI Flow Through
    CASG404
    Role: Principal Investigator
    ACRI #034144     (ROMERO, JOSE R)Jan 1, 2013 - Sep 27, 2017
    UAMS ACHRI Flow Through
    CASG401 (ACHRI 034144)
    Role: Principal Investigator
    ACRI#034144     (ROMERO, JOSE R)Jan 1, 2013 - Sep 27, 2017
    UAMS ACHRI Flow Through
    CASG401 (ACHRI 034144)
    Role: Principal Investigator
    K23AG038444     (ROMERO, JOSE RAFAEL)Aug 15, 2011 - May 31, 2017
    NIH
    Risk Factors, Genetics and Cognition in Cerebral Microbleeds: Framingham Study
    Role: Principal Investigator
    R01HL096518     (ROMERO, JOSE R)Apr 25, 2009 - Mar 31, 2014
    NIH/NHLBI
    Aldosteron, Intracellular Leukocyte Magnesium and Inflammation in Diabetes
    Role: Principal Investigator
    R21ES014462     (ROMERO, JOSE R)Jan 25, 2006 - Nov 30, 2008
    NIH/NIEHS
    Disruption of the Myofibroblast Phenotype by Flavonoids
    Role: Principal Investigator
    R03DK064841     (ROMERO, JOSE R)Sep 20, 2003 - Aug 31, 2007
    NIH/NIDDK
    CELLULAR MAGNESIUM DYSFUNCTION IN DIABETES
    Role: Principal Investigator
    K01DK002817     (ROMERO, JOSE R)Sep 30, 2000 - Jun 30, 2004
    NIH/NIDDK
    INSULIN REGULATED NA+ AND CA2+ TRANSPORT IN HYPERTENSION
    Role: Principal Investigator
    R03DK053538     (ROMERO, JOSE R)May 1, 1998 - Sep 29, 2000
    NIH/NIDDK
    LYMPHOCYTE CYTOSOLIC CALCIUM IN HYPERTENSION
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Romero JR, Modlin J. Principles and Practice of Infectious Diseases. Coxsackieviruses. 2013.
    2. Romero JR. Feigin & Cherry's Textbook of Pediatric Infectious Diseases. West Nile Virus. 2013.
    3. Hulten KG, Kaplan SL, Lamberth LB, Barson WJ, Romero JR, Lin PL, Bradley JS, Givner LB, Tan TQ, Hoffman JA, Mason EO. Changes in Streptococcus pneumoniae serotype 19A invasive infections in children from 1993 to 2011. J Clin Microbiol. 2013; 51:1294-1297.
    4. Romero JR, Modlin J. Principles and Practice of Infectious Diseases. Introduction to the Human Enteroviruses and Parechoviruses. 2013.
    5. Martin K, Romero JR. Comprehensive Pediatric Hospital Medicine. Central Nervous System Infections. 2013.
    6. Romero JR, Jacobs RF. Textbook of Pediatric Infectious Diseases. Fungal Meningitis. 2013.
    7. Romero JR, Modlin J. Principles and Practice of Infectious Diseases. Polioviruses. 2013.
    8. Stellrecht KA, Lamson DA, Romero JR. Manual of Clinical Microbiology. Entroviruses and parechoviruses. 2013.
    9. Kaplan SL, Barson WJ, Lin PL, Romero JR, Bradley JS, Tan TQ, Hoffman JA, Givner LB, Mason EO Jr. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2013; 32:203-207.
    10. Romero JR. Infections of the Central Nervous System. Viral Meningitis and Aseptic Meningitis. 2013.
    11. Romero JR, Modlin J. Principles and Practice of Infection Diseases. Parechoviruses. 2013.
    12. Martin K, Romero JR. Feigin & Cherry's Textbook of Pediatric Infectious Diseases. St. Louis Encephalitis. 2013.
    13. Romero J. Enteroviruses in Humans. 2012.
    14. Kaplan SL, Barson, W, Lin, P, Romero JR, Bradley, J, Tan, T, Hoffman, J. Early Trends for Invasive Pneumococcal Infections in Children Following the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine. 49th Annual Meeting of the Infectious Diseases Society of America. 2012.
    15. Romero JR. Principles and Practice of Pediatric Infectious Diseases. 292-297. 2012; 43.
    16. McKee SG, Linam WM, Romero JR. Methicillin-resistant Staphylococcus aureus epidural abscesses in children. J Investigative Med. 2012; 40.
    17. Martin KC, Romero JR. Curbside Consultation in Pediatric Infectious Diseases : 49 clinical questions. What Are the Best Prophylactic Measures to Tell Families to Use to Prevent Tick Bites? At What Age Are Agents Such as DEET and Picaridin Safe to Use?. 2012.
    18. Martin KC, Romero JR. Curbside Consultation in Pediatric Infectious Diseases : 49 clinical questions. In What Part of the United States is Lyme Disease Seen, How is Diagnosis Confirmed, and What is the Appropriate Treatment?. 2012.
    19. Demissie DE, Kaplan SL, Romero JR, Leake JAD, Barson WJ, Halasa NB, Byington CL, Shetty AK, Tan TQ, Hoffman JA, Lin PL, Edwards KM, Mason EO, Cooperstock MS. Neutrophil Profile at Diagnosis of Invasive Meningococcal Infection in Chil. Pediatric Academic Societies' Meeting. 2012.
    20. Linam WM, Gilliam CH, Honeycutt MD, Wisdom CM, Swearingen CJ, Romero JR. Parental Perceptions about Mandatory Influenza Immunization of Pediatric Healthcare Workers. Pediatric Academic Societies' Meeting. 2012.
    21. Martin KC, Romero JR. Curbside Consultation in Pediatric Infectious Diseases : 49 clinical questions. What Is the Best Empiric and/or Prophylactic Therapy for a Child in Whom You Suspect a Tick-borne Infection?. 2012.
    22. Martin KC, Romero JR. Curbside Consultation in Pediatric Infectious Disease: 49 clinical questions. When Are Tick-borne Infections Typically Seen in the United States, and When Does the Peak Time Occur?. 2012.
    23. Bell J, Anderson EJ, Greene WH, Romero JR, Merchant M, Selvarangan R. A Multicentered evaluation of the performance characteristics of the BD Veritor System for rapid RSV detection. 50th Annual Meeting of the Infectious Diseases Society of America. 2012.
    24. Romero JR. Cecil Medicine. Enteroviruses (Poliovirus, Coxsakieviruses, Echoviruses, and Others). 2011.
    25. Romero JR, Rothbart HA, Nyquist AC, Nolte F. Enteroviral Meningitis Does Not Exclude Concurrent Bacterial Meningitis, Authors’ Reply. J Clin Micro. 2011; 49:3440-3441.
    26. Romero J. Rudolph's Pediatrics. Enteroviruses. 2011.
    27. Sanders RC, Diokno RM, Romero JR. MRSA Infections in Children. J AR Med Soc. 2011; 107:287-290.
    28. Romero JR. Rudolph's Pediatrics. Enterovirus Infections. 2011; 306.
    29. Nolte FS, Tang YW, Robinson CC, Rogers B, Kehl KS, Rand KH, Oberste MS, Rotbart HA, Romero JR, Nyquist AC, Persing DH. Evaluation of a Rapid and Completely Automated Real-time Reverse Transcriptase Polymerase Chain Reaction Assay for the Diagnosis of Enteroviral Meningits. J Clin Micro. 2011; 49:528-533.
    30. Stellrecht KA, Lamson DA, Romero JR. Entroviruses and parechoviruses. Manual of Clinical Microbiology. 2011; 1388-99.
    31. Kimberlin DW, Shalabi M, Abzug MJ, Lang D, Jacobs RF, Storch G, Bradley JS, Wade K, Ramilo O, Romero JR, Shelton M, Leach C, Guzamn-Cottrill J, Robinson J, Abughali N, Englund J, Griffin J, Jester P, Cloud GA, Whitley RJ. Safety of oseltamivir vs. adamantanes in children under 12 months of age: A retrospective chart review. Pediatr Infect Dis J. 2010; 29:195-198.
    32. Romero JR, Stewart DL, Busyman EK, Fernandes AW, Jafri HS, Mahadevia PJ. Serious Early Childhood Wheezing Following Respiratory Syncytial Virus Lower Respiratory Tract Illness in Preterm Infants. Clin Ther. 2010; 32:2422-2432.
    33. Romero JR, Linam WM, Honeycutt M, Wisdom C. Clinical Characteristics of Infants <6 Months of Age Hospitalized with 2009 H1N1 Influenza Virus Infection. Pediatric Research. 2010.
    34. Romero JR, O'Connor J. Pediatric Practice: Gastroenterology. Viral Hepatitis. 2010; 24.
    35. Graham J, Shirm SW, Storm E, Linam WM, Romero JR. Impact of 2009 H1N1 Influenza on a Pediatric Emergency Department. Pediatric Research. 2010.
    36. Romero JR, Et al. Serious early childhood wheezing following respiratory syncytial virus lower respiratory tract infections in preterm infants. 2010.
    37. Romero J. Antimicrobial Therapy and Vaccines, Volume II. Enteroviruses (Coxsackieviruses, Echoviruses and Numbered Enteroviruses) and Parechoviruses. 2010.
    38. Carbonell-Estrany X, Simoes EAF, Dagan R, Hall CB, Harris B, Hultquist M, Connor EM, Losonsky GA, Romero JR. Motavizumab for Prophylaxis of Respiratory Syncytial Virus in High-Risk Children: A Noninferiority Trial. Pediatrics. 2010; 125:e35-e51.
    39. Juretschko SM, Romero JR, Harik N. Failur of Automated Identification Systems to Detect Methicillin Resistance of Staphylococcus aureus in Patients with Cystic Fibrosis. Infectious Diseases Society of America. 2010.
    40. Romero JR, O'Connor J. Pediatric Practice: Gastroenterology, Hepatology, and Nutrition. Viral Hepatitis. 2010.
    41. Stewart D, Romero JR, Busyman E, Fernandes AW, Mahadevia PJ. Healthcare costs of preterm infants due to medically attended respiratory syncytial virus lower respiratory infection in the first year of life. Curr Med Res Opin. 2009; 25:2795-80.
    42. Romero J. Textbook of Pediatric Infectious Diseases. West Nile virus infections. 2009; 188.
    43. Jurectschko S, Beavers-May TK, Hemphill C, Romero JR, Stovall SH. Superior Detection of Kingella kingae and Staphylococcus aureus in pediatric osteoarticular infections using molecular assays. 2009.
    44. Juretschko,SM, Romero JR, Harik,N. Failure of Automated Identification Systems to Detect Methicillin Resistance of Staphylococcus aureus in Patients with Cystic Fibrosis. 47th Annual Infectious Diseases Society of America Meeting. 2009.
    45. Romero JR. Clinical Virology. Enteroviruses. 2009; pp 1031-1062.
    46. Stewart D, Romero J, Buysman EK, Fernandes AW, Mahadevia PJ. Total health care cost of preterm infants with medically attended respiratory syncytial virus lower respiratory tract infection. Infectious Diseases Society of America. 2008; 495 Abstract K - 1429.
    47. Romero J, Varman M, Barton L. Neurologic Manifestations of Pediatric Infectious and Immunologic Diseases. Togaviruses. 2008.
    48. Romero J, Simonsen KA. Powassan Encephalitis and Colorado Tick Fever. Infectious Diseases Clinics of North America. 2008; 22:545-559.
    49. Varman MV, Romero J, Cusick RA, Esposito PW, Armstrong D. Polymicrobial wound infection and nerve injury secondary to a non-human primate bite. Infect Med. 2008; 25:120-127.
    50. Romero J. Neurologic Manifestations of Pediatric Infectious and Immunologic Diseases. Arboviruses. 2008.
    51. Newland JG, Romero J. Neurologic Manifestations of Pediatric Infectious and Immunologic Diseases. Myxoviruses. 2008.
    52. Romero J. Neurologic Manifestations of Pediatric Infectious and Immunologic Diseases. Orthopoxviruses. 2008.
    53. Witt D, Marcon M, Romero J, Sawyer M, Storch G, Dunn J, Schnurr D, Kok W. Multi-Center Evaluation of a Real Time NASBA Best for Detection of Enterovirus in Cerebrospinal Fluid From Pediatric Patients. 24th Annual Clinical Virology Symposium. 2008.
    54. Romero J. Group B Coxsackievirus Infections in Children. Curr Top Microbiol Immunol. 2008; 323:223-240.
    55. Newland JG, Romero J. The Encyclopedia of Public Health. Enteroviruses. 2008.
    56. Truemper EJ, Romero J. West Nile virus. Pediatr Annals. 2007; 36:414-22.
    57. Jafri HS MD, Ramilo O, Makari D, Charsha-May D, Romero J. Diagnostic virology practices for respiratory syncytial virus (RSV) and influenza virus among children in the hospital setting: a nationa survey. Pediatr Infect Dis J. 2007; 26:956-58.
    58. Belshe RB, Edwards KM, Vesikari T, Black SV, Walker RE, Hultquist M, Kemble G, Connor EM, Romero J. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med. 2007; 356:685-696.
    59. Mix AC, Romero J. Comprehensive Pediatric Hospital Medicine. Central Nervous System Infections. 2007.
    60. Newland JG, Romero J. Diagnosis fo viral encephalidites: Zoonotic-associated viruses. Concise Reviews in Pediatric Infectious Diseases, Pediatr Infect Dis J. 2006; 25(8):739-41.
    61. Herrera V, Babcock B, Bastola DR, Romero J, Gebhart C. Performance evaluation of an in-house enterovirus assay over a two year period. 22nd Annual Clinical Virology Symposium. 2006.
    62. Romero J. Manual of Clinical Microbiology. Entroviruses and parechoviruses. 2006.
    63. Ramilo O, Romero J, Jafri H, Makari D, Charsha-May D. Diagnostic testing for respiratory syncytial virus and influenza in the hospital setting: A national survey. American Academy of Pediatrics National Conference and Exhibition. 2005.
    64. Bastola DR, Romero J. Molecular epidemiology of Coxsackievirus B3 (CBV3) in the United States: 1949-1998. 24th Annual Meeting of the American Society for Virology. 2005; W27-8.
    65. Varman M, Romero J, Cornish NE, Manley J, Meza JL, Zach TL, Chartrand SA. Characterization and mechanisms of resistance of group B streptococcal isolates obtained at a community hospital. Euro J Clin Microbiol Infect Dis. 2005; 24:431-433.
    66. Romero J, Stacy RD. Minority Behavioral Risk Factor Survey in Douglas County: A Special Report to Nebraska Office of Minority Health. A Collaborative report with Douglas, Sarpy/Cass County, Nebraska Health Departments, Urban League of Nebraska, Chicano Awareness Center, University of Nebraska Medical Center, and University of Nebrask at Omaha. 2004; 1-34.
    67. Romero J, Cohen A, Boron M, Rankin M, Synagis Outcomes Registry Study Group. Respiratory Syncytial Virus (RSV) prophylaxis in minority populations; results from the Palivizumab Outcomes Registry 2002-2003. Pediatric Research. 2004; 237A.
    68. Newland JG, Romero J. Examination of the plasticity of the puff binding region of Coxsackievirus B3 (CVB3). American Academy of Pediatrics National Conference and Exhibition. 2004; Section on Residents.
    69. Romero J. Respiratory Syncytial Virus (RSV) prophylaxis in minority populations; results from the Palivizumab Outcomes Registry 2002-2003. 2004.
    70. Romero J, Ramilo O, Jafri H, Makari D, Charsha-May D. Diagnostic virology practices for respiratory syncytial virus (RSV) and influenza virus among children in the hospital setting: a national survey. Infectious Diseases Society of America. 2004; 129.
    71. Romero J. Experience with limited Phase I smallpox vaccination in a Midwestern children's hospital. 2004.
    72. Romero J, Allensworth CD, Pour AM. Experience with limited Phase I smallpox vaccination in a Midwestern children's hospital. Pediatric Research. 2004; 4.
    73. Romero J. Diagnostic virology practices for respiratory syncytial virus (RSV) and influenza virus among children in the hospital setting: a nationa survey. 2004.
    74. Romero J. Impact of PCR detection of evteroviral (EV) infection of the management of febrile neonates. 2003.
    75. Dunn JJ, Bradrick SS, Chapman NM, Tracy SM, Romero J. The stem loop II within the 5' nontranslated region of clinical Coxsackievirus B3 genomes determines cardiovirulence phenotype in murine model. J Infect Dis. 2003; 187:1552-1561.
    76. Varman M, Romero J, Cornish NE, Yam PA. Time to detection of respiratory viruses using meixed cell shell vial cultures: 2 vs. 5 days. 41st Annual Infectious Diseases Society of America Meeting, Program and Abstracts. 2003; 92.
    77. Romero J, Allensworth C, Pour AM. Evaluation of phase I vaccination in Douglas County, Nebraska. Infectious Diseases Society of America. 2003; 173.
    78. Romero J. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998-2002: Results from four years of palivizumab usage. Pediatr Infect Dis J. 2003; 22(2):Supp: 46-54.
    79. Romero J, Rotbart HA. Manual of Clinical Microbiology. Enteroviruses. 2003.
    80. Newland JG, Romero J, Varman M, Drake C, Holst A, Safranek T, Subbarao K. Encephalitis associated with influenza B infection in two children and a review of the literature. Clin Infect Dis. 2003; 36:e87-95.
    81. Newland JG, Romero J, Sarica A, Lych JC. Impact of PCR detection of evteroviral (EV) infection of the management of febrile neonates. Pediatric Research. 2003; 4.
    82. Romero J, Newland JG. Viral Meningitis and Encephalitis: Traditional and emerging viral agents. Semin Pediatr Infect Dis. 2003; 14:72-82.
    83. Romero J, Kimberlin DW. Molecular diagnosis of viral infections of the central nervous system. Clin Lab Med. 2003; 23:843-865.
    84. Abzug MJ, Cloud G, Bradley J, Sánchez P, Romero J, Powell D, Lepow M, Mani C, Capparelli EV, Blount S, Lakeman F, Whitley RJ, Kimberly DW, Collaborative Antiviral Study Group. Double blind, placebo-controlled trial of pleconaril in infants with enterovirus meningitis. Pediatr Infect Dis J. 2003; 22(4):335-341.
    85. Romero J. Spectrum of neonatal enteroviral disease over an 8-year period. 2002.
    86. Romero J. Changing susceptibility of group B Streptococcus from a community hospital in a mid-sized Midwestern city. 2002.
    87. Romero J. Diagnosis and management of enteroviral infections of the central nervous system. Curr Infect Dis Rep. 2002; 4:309-316.
    88. Romero J, Newland JG. Antimicrobial Therapy and Vaccines. Enteroviruses (Polioviruses, coxsackieviruses, echoviruses and numbered enteroviruses). 2002.
    89. Varman M, Cornish NE, Zach TL, Romero J. Changing susceptibility of group B Streptococcus from a community hospital in a mid-sized Midwestern city. Pediatric Research. 2002.
    90. Newland JG, Romero J, Sarica A, Zach TL, Linder K. Spectrum of neonatal enteroviral disease over an 8-year period. Infectious Diseases Society of America. 2002; 50.
    91. Tracy S, Drescher KM, Chapman NM, Kim KS, Carson SD, Pirruccello S, Lane PH, Romero J, Leser JS. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: Inoculating NOD mice with CVB markedly lowers diabetes incidence. J Virol. 2002; 76(23):12097-12111.
    92. Romero J. Molecular epidemiology of coxsackievirus B3 in the United States: 1949-1998. 2001.
    93. Rotbart HA, Webster AD, Pleconaril Treatment Registry Group. Treatment of potentially life-threatening enterovirus with pleconaril. Clin Infect Dis. 2001; 32:228-235.
    94. Boyd ZS, Bradrick SS, Cornish N, Carden BM, Romero J. Mutations within the IRES of echovirus 12 confer a novel pathogenic phenotype to and echovirus 12-coxsackeivirus B3 chimera. 30th Annual Meeting of the American Society for Virology. 2001.
    95. Romero J. Pleconaril: A novel antipicornaviral drug. Exp Opin Investig Drugs. 2001; 10(2):369-379.
    96. Romero J. Mutations within the IRES of echovirus 12 confer a novel pathogenic phenotype to and echovirus 12-coxsackeivirus B3 chimera. 2001.
    97. Willis TMS, Hopp RJ, Romero J, Larsen PD. The protective effect of brachial plexus palsy in Purpura fulminans. Pediatr Neurol. 2001; 24(5):379-381.
    98. Bradrick SS, Romero J. Polioviruses. 2001; 1-7.
    99. Newland JG, Romero J, Subbarao K, Safranek T. Encephalitis associated with influenza B infections: A case series in children. Infectious Diseases Society of America. 2001; 66.
    100. Parasuraman TV, Frenia K, Romero JR. Enteroviral meningitis: Cost of illness and considerations for the economic evaluation of potential therapies. Pharmacoeconomics. 2001; 19(1990):3-12.
    101. Kimberlin DW, Lin CY, Jacobs RF, Et al.,. Natural history of neonatal herpes simplex virus infections. Pediatrics. 2001; 108(2004):223-229.
    102. Romero J. Encephalitis associated with influenza B infections: A case series in children. 2001.
    103. Romero J. Enteroviruses in humans. 2001; 1-7.
    104. Bradrick SS, Lieben EA, Carden BM, Romero J. A predicted secondary structural domain within the internal ribosome entry site of echovirus 12 mediates a cell type specific block to viral replication. J Virol. 2001; 75(14):6472-6481.
    105. Romero J. Further mapping of the coxsackievirus B3 (CVB3) 5' nontranslated region (5'NTR) cardiovirulence determinant. 2000.
    106. Romero J. Identification of the major determinant of cardiovirulence of coxsackievirus B3. 2000.
    107. Parasuraman TV, Deverka PA, Toscini MR, Meningitis Consensus Panel. Estimating the economic impact of viral meningitis in the United States. Infect Med. 2000; 17:417-427.
    108. Dunn JJ, Romero J, Wasserman R, Rotbart HA. Stable enterovirus genome over a seven-year period in a patient with agammaglobulinemia and chronic infection. J Infect Dis. 2000; 182:298-301.
    109. Bradrick SS, Carden BM, Dunn JJ, Romero J. Further mapping of the coxsackievirus B3 (CVB3) 5' nontranslated region (5'NTR) cardiovirulence determinant. 29th Annual Meeting of the American Society for Virology. 2000.
    110. Willian S, Tracy S, Chapman N, Leser S, Romero J, Shapiro B, Currey K. Mutations in a conserved enteroviral RNA oligonucleotide sequences affect positive strand viral RNA synthesis. Arch Virol. 2000; 145(10):2061-2086.
    111. Romero J, Tracy SM, Chapman NM, Dunn JJ. Identification of the major determinant of cardiovirulence of coxsackievirus B3. Pediatric Research. 2000.
    112. Dunn JJ, Chapman N, Tracy S, Romero J. Genomic determinants of cardiovirulence in coxackievirus B3 clinical isolates: Localizaion to the 5' nontranslated region. J Virol. 2000; 74:4787-4794.
    113. Romero J. Coxsackievirus B3 (CVB3) genotypes in the United States (US). 1999.
    114. Romero J. Molecular epidemiology of coxsackievirus B3 (CVB3) in the United States--1954-1979. 1999.
    115. Romero J. Cardiovirulence determinants among naturally occurring isolates of coxsackievirus B3 reside within the 5' nontranslated region. 1999.
    116. Romero J. Pleconaril treatment of vaccine-acquired poliovirus. 1999.
    117. Modlin J, Reiss M, Romero J, Et al. Development and validation of a decision analytic framework to evaluate the economic impact of suspected meningitis. Internationa Society for Pharmacoeconomics and Outcomes Research Meeting. 1999.
    118. Modlin J, Reiss M, Romero J. Estimating the economic impact of viral meningitis in the United States. Internationa Society for Pharmacoeconomics and Outcomes Research Meeting. 1999.
    119. Dunn JJ, Tracy SM, Chapman NM, Romero J. Deteminants of cardiovirulence in coxsackievirus B3 (CVB3) clinical isolates localize to the 5' nontranslated regions (5'NTR). 18th Annual Meeting of the American Society for Virology. 1999.
    120. Sawyer MH, Saez-Llorenz X, Aviles CL, O'Ryan M, Romero J. Oral Pleconaril reduces the duration and severity of enteroviral meningitis in children. Pediatric Research. 1999.
    121. Modlin J, Reiss M, Romero J, Et al. Estimating the economic impact of viral meningitis in the United States. Internationa Society for Pharmacoeconomics and Outcomes Research Meeting. 1999.
    122. Romero J, Gross T, Abromowitch M, Jung L. Pleconaril treatment of vaccine-acquired poliovirus. Pediatric Research. 1999.
    123. Bradrick SS, Lieben EA, Romero J. Nonreceptor determinants of growth restriction reside within the echovirus 12 5' nontranslated region. 18th Annual Meeting of the American Society for Virology. 1999.
    124. Romero J. Reverse transcription-polymerase chain reaction detection of the enteroviruses: Overview and clinical utility in pediatric enteroviral infections. Arch Pathol Lab Med. 1999; 123:1161-1169.
    125. Romero J, Dunn JJ, Tracy SM, Et al. Cardiovirulence determinants among naturally occurring isolates of coxsackievirus B3 reside within the 5' nontranslated region. Pediatric Research. 1999.
    126. Heuermann KG, Romero J, Abromowitch MA, Gordon BG, Gross TG. Fatal coagulase negative staphylococci infection after bone marrow transplantation in a patient with persistent adverse reactions to vancomycin. Am J Pediatr Hematol/Oncol. 1999; 21:80-81.
    127. Romero J. Enteroviruses: Diagnosis, screening, and surveillance. Infect Med. 1999; 16(Suppl D ):11-20.
    128. Romero J, Schnurr D, Oberste MS, Bradrick SS, Et al. Molecular epidemiology of coxsackievirus B3 (CVB3) in the United States--1954-1979. 18th Annual Meeting of the American Society for Virology. 1999.
    129. Romero J, Bradrick SS, Schnurr D, Oberste S, Et al. Coxsackievirus B3 (CVB3) genotypes in the United States (US). Infectious Diseases Society of America. 1999; 164.
    130. Romero J. Molecular and phenotypic characterization of a myocarditic coxsackievirus B3 (CVB3) isolate. 1998.
    131. Romero J. Reverse transcription-polymerase chain reaction diagnosis of enterovirus infections in febrile children results in reduced health care expenditures. 1998.
    132. Romero J. Reverse transcription-polymerase chain reaction diagnosis of enterovirus infections in febrile children reduces duration of hospitalization, antibiotic administration and results in reduced health care costs. 1998.
    133. Romero J. Impact of reverse transcription-polymerase chain reaction diagnosis of enterovirus infections on the care of febrile children. 1998.
    134. Romero J, Hinrichs S, Perry D, Et al. Impact of reverse transcription-polymerase chain reaction diagnosis of enterovirus infections on the care of febrile children. Pediatric Research. 1998.
    135. Rotbart HA, Brennan PJ, Fife KH, Romero J, Et al. Enterovirus meninigitis in adults. Clin Infect Dis. 1998; 27(4):896-898.
    136. Romero J, Magelli M, Hinrichs S, Et al. Reverse transcription-polymerase chain reaction diagnosis of enterovirus infections in febrile children results in reduced health care expenditures. Infectious Diseases Society of America. 1998; 201.
    137. Dunn JJ, Tracy SM, Romero J. The 5' untranslated region (5' UTR) of a wild-type coxsackievirus B3 (CBV3) strain attenuates the cardiovirulent phenotype of CBV3/20. 17th Annual American Society for Virology Scientific Program. 1998.
    138. Romero J, Hinrichs S, Perry D, Kruger R, Magelli M. Reverse transcription-polymerase chain reaction diagnosis of enterovirus infections in febrile children reduces duration of hospitalization, antibiotic administration and results in reduced health care costs. 15th Annual Meeting of the Minority Medical Faculty Development Program. 1998.
    139. Romero J, Bures E, Bradrick S, Price C. Molecular epidemiology of coxsackievirus B3 in the United States: 1949-1998. Pediatric Research. 1998.
    140. Romero J, Kirk C, Dunn J, Et al. Molecular and phenotypic characterization of a myocarditic coxsackievirus B3 (CVB3) isolate. Infectious Diseases Society of America. 1998; 134.
    141. Boken DJ, Romero J, Cavalieri SJ. Sphingomonas paucimobilis bacteremia: Four cases and review of the literature. Infect Dis Clin Prac. 1998; 7:286-291.
    142. Romero J. Complete capsid amino acid sequences of 14 wild-type coxsackievirus B3 (CBV3) isolates. 1997.
    143. Romero J. Echovirus-coxsackievirus chimeras for the evaluation of the role of the echovirus 5' nontranslated region (5' NTR) in pathogenesis. 1997.
    144. Chapman NM, Romero J, Pallansch MA, Tracy S. Sites other than nucleotide 234 determin cardiovirulence in natural isolates of coxsackievirus B3. J Med Virol. 1997; 52:258-261.
    145. Romero J, Lieben E, Tracy SM, Et al. Echovirus-coxsackievirus chimeras for the evaluation of the role of the echovirus 5' nontranslated region (5' NTR) in pathogenesis. Pediatric Research. 1997.
    146. Romero J, Price C, Dunn JJ. Genetic divergence among the group B coxsackieviruses. Curr Top Microbiol Immunol. 1997; 223:81-96.
    147. Romero J, Dunn JJ, Leser JS, Et al. Complete capsid amino acid sequences of 14 wild-type coxsackievirus B3 (CBV3) isolates. 16th Annual American Society for Virology Scientific Program and Abstracts. 1997.
    148. Romero J. Potential health care cost savings from PCR-based rapid diagnosis of enteroviral meningitis. 1996.
    149. Romero J. Genetic diversity and molecular epidemiology among coxsackievirus B2 (CVB2) during a community outbreak. 1996.
    150. Tracy S, Chapman NM, Romero J, Ramsingh AI. Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease. Trends Microbiol. 1996.
    151. Ehrhardt AF, Sanders CC, Romero J, Leser JS. Sequencing and analysis of four new Enterobacter ampD alleles. Antimicrob Agents Chemother. 1996; 40(8):1953-1956.
    152. Romero J, Tracy SM, Pong AL, Hinrichs SH, Leser JS. Genetic diversity and molecular epidemiology among coxsackievirus B2 (CVB2) during a community outbreak. Pediatric Research. 1996.
    153. Tracy S, Chapman N, Ramsingh A, Romero J, Curry K, Shapiro B, Barry W, Chin T, Hufnagel G. The Role of Immune Mechanisms in Disease. Coxsackievirus genetics and the cardiovirulent viral phenotype. 1996.
    154. Romero J, Hinrichs SH, Cavalieri SJ, Perry D, Leser JS, Onyeuku J. Potential health care cost savings from PCR-based rapid diagnosis of enteroviral meningitis. Pediatric Research. 1996.
    155. Rotbart HA, Brennan PJ, Fife KH, Romero J, Et al. Enterovirus (EV) meningitis (M) in adults. 36th Interscience Conference on Antimicrobials Agents and Chemotherapy Abstracts. 1996.
    156. Tracy S, Chapman N, Romero J, Currey K, Shapiro B. Mutations at position 234 in coxsackieviral 5' NTR. 15th Annual American Society for Virology Scientific Program and Abstracts. 1996.
    157. Romero J, Tracy SM, Chapman NM, Leser JS. Chimeric coxsackievirus B3 as a vehicle to study the echovirus 5' nontranslated region (5'NTR). 15th Annual American Society for Virology Scientific Program and Abstracts. 1996.
    158. Ehrhardt A, Sanders C, Romero J, Leser J. Sequencing and analysis of four new Enterobacter ampD alleles. Interscience Conference on Antimicrobial Agents and Chemotherapy. 1995.
    159. Tu Z, Chapman NM, Hufnagel G, Tracy S, Romero J, Barry WH, Zhao L, Curry K, Shapiro B. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region. J Virol. 1995; 69(8):4607-4618.
    160. Romero J, Rotbart HA. Sequence analysis of the downstream 5' nontranslated region of seven echoviruses with different neurovirulence phenotypes. J Virol. 1995; 69:1370-1375.
    161. Rotbart HA, Romero J. Human Enterovirus Infections. Laboratory diagnosis of enterovirus infections. 1995.
    162. Chapman N, Tu Z, Hufnagel G, Tracy S, Romero J, Barry W, Zhao L, Currey K. Determination of genetics and mechanism of coxsackievirus B3 cardiovirulence. 95th General Meeting of American Society for Microbiology. 1995.
    163. Romero J, Leser JS, Tracy S, Chapman N, Winters D. Amino acid sequence variation in the major surface loop (VP2 E-F) of the cell receptor site from 8 clinical isolates of coxsackievirus B3. Pediatric Research. 1995.
    164. Levin MJ, Romero J. Current Pediatric Diagnosis and Treatment. Infections: Viral and Rickettsial. 1994.
    165. Romero J, Ogle JW. Arboviral infections in the US: Encephalitis, Colorado tick fever and hantavirus. Seminars in Pediatric Infectious Diseases. 1994; 5:95-101.
    166. Romero J, Rotbart HA. PCR- Based Diagnostics of Infectious Organisms. Polymerase chain reaction strategies for the detection of the human enteroviruses. 1994.
    167. Romero J. Pediatric tuberculosis. Current Opinion in Infectious Diseases. 1994; 7:374-381.
    168. Romero J, Tracy S, Chapman N, Gauntt C. Genetic variation in coxsackievirus B3 genomes. 13th Annual American Society for Virology Scientific Program and Abstracts. 1994.
    169. Romero J. Genomic Variation of Coxsackievirus B3. 1994.
    170. Romero J, Rotbart HA. Sequence diversity among enteroviruses with different neurovirulence phenotypes. Pediatric Research. 1993.
    171. Romero J. Sequence diversity among enteroviruses with different neurovirulence phenotypes. 1993.
    172. Romero J, Rotbart HA. Selective amplification and partial sequence analysis of the 5'NTR of seven enteroviruses with different neurovirulence phenotypes. 12th Annual American Society for Virology Scientific Program and Abstracts. 1993.
    173. Romero J, Rotbart HA. Selective amplification and partial sequence analysis of the 5'NTR of seven enteroviruses with different neurovirulence phenotypes. 1993.
    174. Romero J. Tick-borne diseases of the United States. Contagious Comments. 1992; 12:1-5.
    175. Romero J. Tick-borne diseases of the United States- Update 1992. 1992.
    176. Doski JJ, Priebe CJ Jr., Driessnak-Hill M, Smith T, Kane P, Romero J. Corticosteroids in management of unresectable plasma cell granuloma (inflammatory psudeotumor) of the lung. J Pediatr Surg. 1991; 26:1064.
    177. Biancaniello TM, Romero J. Bacterial endocarditis after adjustment of orthodontic appliances. J Pediatr. 1991; 118:248.
    178. Romero J, Rotbart HA. Discriminant enteroviral replication in U937 cells: a candidate model for monocyte/enterovirus interactions. 30th Interscience Conference on Antimicrobial Agents and Chemotherapy Program and Abstracts. 1990.
    179. Romero J, Rotbart HA. Discriminant enteroviral replication in U937 cells: a candidate model for monocyte/enterovirus interactions. 1990.
    180. Romero J, Putnak R, Wimmer E. Enteroviral capsid protein VP3 as a group antigen for the enteroviruses. 1988.
    181. Romero J, Putnak R, Wimmer E. Enteroviral capsid protein VP3 as a group antigen for the enteroviruses. Pediatric Research. 1988.
    182. Wimmer E, Kuhn RJ, Toyoda H, Nicklin MJH, Diamond DC, Murray MG, Romero J. Chemical and biologic properties of the poliovirion. Biologic Chem. 1986.
    183. Romero J, Putnak R, Wimmer E. The use of poliovirus proteins VP3 and 2C as group antigens for the detection of enteroviral infections by indirect immunofluorescence. Poster session presented. 1986.
    184. Romero J, Putnak R, Wimmer E. The use of poliovirus proteins VP3 and 2C as group antigens for the detection of enteroviral infections by indirect immunofluorescence. Pediatric Research. 1986.
    Same Department Expand Description
    Search Department